By Sabrina Gérard, Head of Sustainability and Agility at Datwyler The global pharmaceutical industry has long had to triage priorities to deliver for its customers and society at large. Developing and delivering new therapeutics is time-and energy-intensive, and the pandemic has starkly highlighted the challenges the world faces with supply chains and drug delivery systems.   […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!